Medindia LOGIN REGISTER
Medindia
Advertisement

NeoStem to Present at ROTH Capital Partners 22nd Annual OC Growth Stock Conference

Thursday, March 11, 2010 General News
Advertisement
NEW YORK, March 9 NeoStem, Inc. (NYSE: NBS)("NeoStem" or the "Company"), an international biopharmaceutical company withoperations in the U.S. and China, announced today that the Company willpresent at the upcoming ROTH Capital Partners 22nd Annual OC Growth StockConference to be held on March 15-17, 2010.
Advertisement

Robin Smith, M.D., NeoStem's CEO and Chairman of the board of directors,will be available for one-on-one meetings with institutional investors onMarch 15 at the conference.
Advertisement

About NeoStem, Inc.

NeoStem, Inc. is engaged in the development of stem cell-based therapies,pursuit of anti-aging initiatives and building of a network of adult stem cellcollection centers in the U.S. and China that are focused on enabling peopleto donate and store their own (autologous) stem cells for their personal usein times of future medical need. The Company also has licensed various stemcell technologies, including a worldwide exclusive license to VSEL(TM)technology which uses very small embryonic-like stem cells, shown to haveseveral physical characteristics that are generally found in embryonic stemcells, and is pursuing the licensing of other technologies for therapeutic use.NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye,manufactures and distributes generic antibiotics in China. For moreinformation, please visit: http://www.neostem.com .Presentation Date: Monday, March 15, 2010 Time: 8 a.m. Pacific Time Venue: The Ritz-Carlton, Laguna Niguel One Ritz Carlton Dr Dana Point, CA 92629

SOURCE NeoStem, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close